Efficacy and Safety of Umeclidinium Added to Fluticasone Propionate/Salmeterol in Patients with COPD: Results of Two Randomized, Double-Blind Studies

Por Siler, Thomas M., Kerwin, Edward, Singletary, Karen, Brooks, Jean, Church, Alison
Publicado no COPD (2016)

Safety and Efficacy of Revefenacin and Formoterol in Sequence and Combination via a Standard Jet Nebulizer in Patients with Chronic Obstructive Pulmonary Disease: A Phase 3b, Rando...

Por Siler, Thomas M., Moran, Edmund J., Barnes, Chris N., Crater, Glenn D.
Publicado no Chronic Obstr Pulm Dis (2020)

Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect

Por Siler, Thomas M, LaForce, Craig F, Kianifard, Farid, Williams, James, Spangenthal, Selwyn
Publicado em 2014

A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 μg on health-related quality of life in patients with COPD

Por Siler, Thomas M, Donald, Alison C, O’Dell, Dianne, Church, Alison, Fahy, William A
Publicado no Int J Chron Obstruct Pulmon Dis (2016)

Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with mode...

Por Kerwin, Edward M, Siler, Thomas M, Arora, Samir, Darken, Patrick, Rose, Earl, Reisner, Colin
Publicado no Int J Chron Obstruct Pulmon Dis (2018)

Efficacy and Safety of Twice-Daily Glycopyrrolate Versus Placebo in Patients With COPD: The GEM2 Study

Por Kerwin, Edward, Siler, Thomas M., Korenblat, Phillip, White, Alexander, Eckert, Joerg H., Henley, Michelle, Patalano, Francesco, D’Andrea, Peter
Publicado no Chronic Obstr Pulm Dis (2016)